Darryl Rideout

Title: The Innovations of Darryl Rideout

Introduction

Darryl Rideout is an accomplished inventor based in Parkton, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address neurovascular and neurogenic pain.

Latest Patents

Darryl Rideout holds a patent for a purified Isometheptene compound. This invention relates to the synthesis, purification, and characterization of an Isometheptene isomer mucate crystal, specifically the (R)-enantiomer. The (R)-Isometheptene enantiomer is recognized for its selective activity as a centrally acting ligand for Imidazoline subtype 1 (I1) receptor sites. This compound is believed to be an effective antihypertensive agent with fewer side effects compared to its racemate form. The invention aims to provide relief for conditions such as episodic tension-type headaches (ETTH) and includes methods of synthesis and treatment.

Career Highlights

Darryl Rideout is associated with Tonix Pharma Holdings Limited, a company focused on developing innovative pharmaceutical solutions. His work has contributed to advancements in treatments for migraine and other related conditions.

Collaborations

Darryl has collaborated with notable colleagues, including Seth Lederman and Bruce Daugherty, to further enhance the research and development of his inventions.

Conclusion

Darryl Rideout's innovative work in the field of pharmaceuticals, particularly with Isometheptene, showcases his commitment to improving treatment options for patients suffering from various types of pain. His contributions are significant in the ongoing quest for effective medical solutions.